Challenges facing the clinical adoption of a new prognostic biomarker: a case study

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Challenges facing the clinical adoption of a new prognostic biomarker : a case study. / Larsen, Trine Schifter; Eugen-Olsen, Jesper; Andersen, Ove; Kirk, Jeanette Wassar.

In: BioSocieties, Vol. 19, No. 2, 2024, p. 159-181.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Larsen, TS, Eugen-Olsen, J, Andersen, O & Kirk, JW 2024, 'Challenges facing the clinical adoption of a new prognostic biomarker: a case study', BioSocieties, vol. 19, no. 2, pp. 159-181. https://doi.org/10.1057/s41292-022-00296-2

APA

Larsen, T. S., Eugen-Olsen, J., Andersen, O., & Kirk, J. W. (2024). Challenges facing the clinical adoption of a new prognostic biomarker: a case study. BioSocieties, 19(2), 159-181. https://doi.org/10.1057/s41292-022-00296-2

Vancouver

Larsen TS, Eugen-Olsen J, Andersen O, Kirk JW. Challenges facing the clinical adoption of a new prognostic biomarker: a case study. BioSocieties. 2024;19(2):159-181. https://doi.org/10.1057/s41292-022-00296-2

Author

Larsen, Trine Schifter ; Eugen-Olsen, Jesper ; Andersen, Ove ; Kirk, Jeanette Wassar. / Challenges facing the clinical adoption of a new prognostic biomarker : a case study. In: BioSocieties. 2024 ; Vol. 19, No. 2. pp. 159-181.

Bibtex

@article{c7bc4b43d6ff4946b73de7f20820eaf3,
title = "Challenges facing the clinical adoption of a new prognostic biomarker: a case study",
abstract = "In this article, we show how a particular biomarker comes into being in an emergency department in a hospital in Copenhagen, Denmark. We explore the contextual becoming of this biomarker, suPAR, through interviews with nurses and physicians and through relational ontology. We find that as a prognostic biomarker suPAR is challenged in it becoming as an object for clinical practice in the emergency department by the power of diagnostic practices and the desire for experience-based scripts that quickly enable the clinician to reach the right diagnosis. Although suPAR is enacted as a promising triage strategy suggesting a low or high risk of disease, the inability to rule out specific diagnoses and producing the notion of secure clinical actions make its non-specificity and prognostic character problematic in clinical practices. Specific diagnostic criteria versus prognostic interpretation and non-specificity risk profiling challenges the way healthcare workers in an emergency department understand the tasks they are set to solve and how to solve them. We discuss how the becoming of suPAR is strengthened through enactments of specificity and engagement in triage strategies and we reflect on it{\textquoteright}s becoming through new diagnostic practices with the need to accommodate diagnostic ambiguity.",
keywords = "Biotechnology, Clinical decision-making, Diagnosis, Professional identity, Prognosis, Relational ontology",
author = "Larsen, {Trine Schifter} and Jesper Eugen-Olsen and Ove Andersen and Kirk, {Jeanette Wassar}",
note = "Publisher Copyright: {\textcopyright} 2023, The Author(s), under exclusive licence to Springer Nature Limited.",
year = "2024",
doi = "10.1057/s41292-022-00296-2",
language = "English",
volume = "19",
pages = "159--181",
journal = "BioSocieties",
issn = "1745-8552",
publisher = "Palgrave Macmillan",
number = "2",

}

RIS

TY - JOUR

T1 - Challenges facing the clinical adoption of a new prognostic biomarker

T2 - a case study

AU - Larsen, Trine Schifter

AU - Eugen-Olsen, Jesper

AU - Andersen, Ove

AU - Kirk, Jeanette Wassar

N1 - Publisher Copyright: © 2023, The Author(s), under exclusive licence to Springer Nature Limited.

PY - 2024

Y1 - 2024

N2 - In this article, we show how a particular biomarker comes into being in an emergency department in a hospital in Copenhagen, Denmark. We explore the contextual becoming of this biomarker, suPAR, through interviews with nurses and physicians and through relational ontology. We find that as a prognostic biomarker suPAR is challenged in it becoming as an object for clinical practice in the emergency department by the power of diagnostic practices and the desire for experience-based scripts that quickly enable the clinician to reach the right diagnosis. Although suPAR is enacted as a promising triage strategy suggesting a low or high risk of disease, the inability to rule out specific diagnoses and producing the notion of secure clinical actions make its non-specificity and prognostic character problematic in clinical practices. Specific diagnostic criteria versus prognostic interpretation and non-specificity risk profiling challenges the way healthcare workers in an emergency department understand the tasks they are set to solve and how to solve them. We discuss how the becoming of suPAR is strengthened through enactments of specificity and engagement in triage strategies and we reflect on it’s becoming through new diagnostic practices with the need to accommodate diagnostic ambiguity.

AB - In this article, we show how a particular biomarker comes into being in an emergency department in a hospital in Copenhagen, Denmark. We explore the contextual becoming of this biomarker, suPAR, through interviews with nurses and physicians and through relational ontology. We find that as a prognostic biomarker suPAR is challenged in it becoming as an object for clinical practice in the emergency department by the power of diagnostic practices and the desire for experience-based scripts that quickly enable the clinician to reach the right diagnosis. Although suPAR is enacted as a promising triage strategy suggesting a low or high risk of disease, the inability to rule out specific diagnoses and producing the notion of secure clinical actions make its non-specificity and prognostic character problematic in clinical practices. Specific diagnostic criteria versus prognostic interpretation and non-specificity risk profiling challenges the way healthcare workers in an emergency department understand the tasks they are set to solve and how to solve them. We discuss how the becoming of suPAR is strengthened through enactments of specificity and engagement in triage strategies and we reflect on it’s becoming through new diagnostic practices with the need to accommodate diagnostic ambiguity.

KW - Biotechnology

KW - Clinical decision-making

KW - Diagnosis

KW - Professional identity

KW - Prognosis

KW - Relational ontology

U2 - 10.1057/s41292-022-00296-2

DO - 10.1057/s41292-022-00296-2

M3 - Journal article

C2 - 36713027

AN - SCOPUS:85146642451

VL - 19

SP - 159

EP - 181

JO - BioSocieties

JF - BioSocieties

SN - 1745-8552

IS - 2

ER -

ID: 371615954